Partner Winston Kirton will moderate a panel at the Food and Drug Law Institute (FDLI) annual conference on May 17, 2023, in Washington, D.C.
His panel is titled “Due Diligence: Ensuring Regulatory Control and Compliance Pre/Post-Acquisition.” Discussion will cover effective pre- and post-acquisition diligence strategies and risk mitigation, as well as how to overcome integration challenges and track and remediate issues that come to light during the due diligence process.